Insufficient scRNA-seq data for expression of HTR2B at single-cell level.
Insufficient scRNA-seq data for expression of HTR2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1082.65 | 257 / 258 | 58% | 3.83 | 133 / 230 |
kidney | 90% | 156.34 | 80 / 89 | 45% | 1.81 | 409 / 901 |
uterus | 98% | 669.35 | 167 / 170 | 37% | 1.78 | 170 / 459 |
thymus | 98% | 210.96 | 638 / 653 | 37% | 0.65 | 221 / 605 |
breast | 62% | 49.61 | 283 / 459 | 56% | 1.70 | 628 / 1118 |
intestine | 78% | 371.37 | 753 / 966 | 24% | 0.95 | 125 / 527 |
ovary | 57% | 47.93 | 103 / 180 | 42% | 1.29 | 179 / 430 |
esophagus | 61% | 391.40 | 879 / 1445 | 34% | 1.33 | 62 / 183 |
bladder | 67% | 79.62 | 14 / 21 | 22% | 0.93 | 113 / 504 |
lung | 43% | 25.83 | 249 / 578 | 44% | 2.39 | 510 / 1155 |
stomach | 44% | 266.82 | 159 / 359 | 39% | 1.95 | 111 / 286 |
pancreas | 7% | 3.09 | 23 / 328 | 75% | 3.33 | 133 / 178 |
blood vessel | 81% | 119.84 | 1086 / 1335 | 0% | 0 | 0 / 0 |
liver | 41% | 22.09 | 92 / 226 | 36% | 1.90 | 147 / 406 |
adipose | 64% | 51.16 | 765 / 1204 | 0% | 0 | 0 / 0 |
heart | 63% | 115.00 | 544 / 861 | 0% | 0 | 0 / 0 |
skin | 19% | 20.04 | 336 / 1809 | 43% | 5.15 | 202 / 472 |
eye | 0% | 0 | 0 / 0 | 55% | 56.77 | 44 / 80 |
prostate | 28% | 15.50 | 68 / 245 | 11% | 0.25 | 57 / 502 |
spleen | 20% | 8.39 | 48 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.78 | 8 / 45 |
brain | 3% | 1.29 | 82 / 2642 | 7% | 0.15 | 46 / 705 |
peripheral blood | 8% | 4.90 | 72 / 929 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.72 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019934 | Biological process | cGMP-mediated signaling |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0071502 | Biological process | cellular response to temperature stimulus |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0001755 | Biological process | neural crest cell migration |
GO_0050795 | Biological process | regulation of behavior |
GO_0003300 | Biological process | cardiac muscle hypertrophy |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0007210 | Biological process | serotonin receptor signaling pathway |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0098664 | Biological process | G protein-coupled serotonin receptor signaling pathway |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0010513 | Biological process | positive regulation of phosphatidylinositol biosynthetic process |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0007208 | Biological process | phospholipase C-activating serotonin receptor signaling pathway |
GO_0048598 | Biological process | embryonic morphogenesis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0002031 | Biological process | G protein-coupled receptor internalization |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0014033 | Biological process | neural crest cell differentiation |
GO_0070528 | Biological process | protein kinase C signaling |
GO_0016310 | Biological process | phosphorylation |
GO_0014827 | Biological process | intestine smooth muscle contraction |
GO_0051000 | Biological process | positive regulation of nitric-oxide synthase activity |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0042310 | Biological process | vasoconstriction |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0003007 | Biological process | heart morphogenesis |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0098666 | Cellular component | G protein-coupled serotonin receptor complex |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0051378 | Molecular function | serotonin binding |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0001587 | Molecular function | Gq/11-coupled serotonin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HTR2B |
Protein name | 5-hydroxytryptamine receptor 2B (Serotonin receptor 2B) 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) |
Synonyms | |
Description | FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin) . Also functions as a receptor for various ergot alkaloid derivatives and psychoactive substances . Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors . Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways . Signaling activates a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and down-stream signaling cascades and promotes the release of Ca(2+) ions from intracellular stores . Plays a role in the regulation of dopamine and 5-hydroxytryptamine release, 5-hydroxytryptamine uptake and in the regulation of extracellular dopamine and 5-hydroxytryptamine levels, and thereby affects neural activity. May play a role in the perception of pain (By similarity). Plays a role in the regulation of behavior, including impulsive behavior . Required for normal proliferation of embryonic cardiac myocytes and normal heart development. Protects cardiomyocytes against apoptosis. Plays a role in the adaptation of pulmonary arteries to chronic hypoxia. Plays a role in vasoconstriction. Required for normal osteoblast function and proliferation, and for maintaining normal bone density. Required for normal proliferation of the interstitial cells of Cajal in the intestine (By similarity). . |
Accessions | B3VRD0 B3VRD5 P41595 Q7Z580 B3VRC5 ENST00000258400.4 |